// App-Quantinova.ai

PB1814 : RARE PHENOTYPE WITH CD33 ABSENT IN ACUTE MYELOID LEUKEMIA MIMICKING MRD POSITIVITY: A CASE REPORT

Researchers

Presenter

  • Leticia O Marani

Principal Investigators

  • Amanda Costa

  • Priscila S Scheucher

  • Katia B B Pagnano

  • Sylvie Freeman

  • Eduardo M Rego

  • Fabiola Traina

Medical Centers

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Neurology, University of Campinas, Campinas, Brazil

  • Neurology, University of Campinas, Campinas, Brazil

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Neurology, University of Campinas, Campinas, Brazil

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Institute of Immunology and Immunotherapy,University of Birmingham,Birminham,Royaume-uni

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Institute of Immunology and Immunotherapy,University of Birmingham,Birminham,Соединённое Королевство

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Neurology, University of Campinas, Campinas, Brazil

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Neurology, University of Campinas, Campinas, Brazil

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Hemocentro,University of Campinas,Campinas,Бразилия

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Neurology, University of Campinas, Campinas, Brazil

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Internal Medicine,Medical School of the University of Sao Paulo,Sao Paulo,Brasile

  • Division of Hematology and Oncology, Department of Medicine,UAB Comprehensive Cancer Center, University of Alabama at Birmingham,Birmingham,United States

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

  • Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology,Ribeirao Preto Medical School at University of Sao Paulo,Ribeirao Preto,Brasil

Locations

  • United States

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Nucleophosmin 1

  • ETV6-RUNX1

  • Fms related tyrosine kinase 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved